Sharescart Research Club logo

Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹12620 Cr.
Stock P/E
68.3
P/B
8.9
Current Price
₹3230.7
Book Value
₹ 361.6
Face Value
10
52W High
₹3594.9
52W Low
₹ 2050.4
Dividend Yield
0.31%

Privi Speciality Che Overview

Business

Privi Speciality Chemicals Ltd. is a leading manufacturer and exporter of aroma chemicals in India. The company specializes in the production of various terpene-based aroma chemicals which are essential ingredients for the fragrance and flavor industry. Their products are primarily used in personal care (soaps, detergents, cosmetics), home care, food & beverages, and pharmaceutical applications. The core business model revolves around backward integration, R&D-led new product development, and serving global as well as domestic fragrance and flavor houses. The company makes money by manufacturing and selling these specialty aroma chemicals and intermediates to B2B customers globally.

Revenue Mix

Privi Speciality Chemicals primarily operates in the Aroma Chemicals segment. While explicit revenue percentages for sub-segments are not always publicly detailed, the vast majority of its revenue is derived from the sale of terpene-based aroma chemicals. The company has been expanding into related specialty intermediates, which form a smaller but growing part of its product portfolio, catering to various industrial applications beyond just fragrances and flavors.

Industry

The company operates within the broader Indian specialty chemicals sector, specifically carving a niche in aroma chemicals. The industry is characterized by increasing demand for differentiated and high-performance chemicals, driven by consumer preferences and technological advancements. Privi is positioned as one of the largest manufacturers of specific terpene-based aroma chemicals in India, competing with both domestic peers and international players. Its strong R&D capabilities and backward integration lend it a competitive edge in its niche, especially against smaller players.

MOAT

Backward Integration: Privi has a significant competitive advantage through its backward integration into key raw materials derived from turpentine oil. This ensures a more secure supply chain, better quality control, and often cost efficiency, reducing its dependence on external suppliers for critical inputs.

R&D and Process Expertise: The company possesses strong research and development capabilities, enabling it to develop new, complex, and high-value aroma chemicals and processes. This allows for product differentiation and caters to evolving customer demands.

Long-standing Customer Relationships: Privi has established long-term relationships with major global and domestic fragrance and flavor houses, which provides stable demand and insights into industry trends.

Scale in Niche: Being one of the largest Indian manufacturers in its specific aroma chemical product categories offers advantages in terms of production efficiency and market presence.

Growth Drivers

Increasing Demand for Fragrances & Flavors: Global and domestic demand for personal care, home care, food & beverages products continues to grow, driving consumption of aroma chemicals.

"China+1" Strategy: Global supply chain diversification, where companies look for alternatives to China, benefits Indian specialty chemical manufacturers like Privi due to their established capabilities and cost competitiveness.

New Product Development & Capacity Expansion: Continuous investment in R&D to launch new aroma chemicals and specialty intermediates, coupled with strategic capacity expansions, will drive future revenue.

Premiumization and Customization: Growing consumer preference for premium and customized fragrance and flavor profiles creates opportunities for higher-value specialty aroma chemicals.

Risks

Raw Material Price Volatility: Key raw materials like turpentine oil (derived from forest products) are subject to significant price fluctuations based on availability, demand, and forestry policies, which can impact profitability.

Environmental Regulations: The chemical industry is subject to stringent environmental laws. Any changes in regulations or non-compliance can lead to operational disruptions, increased costs, or penalties.

Intense Competition: The company faces competition from both domestic and international players, including larger, more diversified chemical companies, which can exert pressure on pricing and market share.

Foreign Exchange Fluctuations: As a significant exporter, Privi is exposed to currency exchange rate volatility, which can affect its realized revenues and profitability.

Capex Execution Risk: The successful and timely execution of planned capacity expansion projects is critical. Delays or cost overruns can impact projected growth and financial performance.

Management & Ownership

Privi Speciality Chemicals Ltd. is promoted by the Bhageria family. Mr. D.B. Bhageria, the Chairman & Managing Director, has been a driving force behind the company's growth and strategy. The promoter group holds a significant stake in the company (typically above 50%), demonstrating strong alignment with long-term performance. The management team generally comprises individuals with extensive experience in the chemical industry, particularly in specialty and aroma chemicals.

Outlook

Privi Speciality Chemicals is well-positioned to capitalize on the sustained growth in demand for aroma chemicals and the broader specialty chemicals sector, particularly benefiting from global supply chain shifts and increasing consumer discretionary spending. Its strong backward integration and R&D capabilities provide a foundation for competitive pricing and product innovation. However, the company faces inherent risks associated with raw material price volatility, stringent environmental regulations, and the capital-intensive nature of chemical manufacturing. Its ability to successfully execute expansion plans, manage input costs effectively, and continue innovating new products will be crucial for maintaining its growth trajectory and profitability in the competitive market.

Privi Speciality Che Share Price

Live · BSE / NSE · Inception: 1985
| |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Privi Speciality Che Quarterly Results

#(Fig in Cr.) Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 404 484 464 533 491 614 559 679 605 722
Other Income 6 8 3 4 2 15 9 0 7 4
Total Income 409 492 467 537 493 628 568 679 611 726
Total Expenditure 314 393 370 423 378 481 427 497 453 541
Operating Profit 96 99 97 115 115 147 141 182 158 184
Interest 24 25 22 22 22 23 24 21 19 18
Depreciation 32 30 32 32 32 35 36 36 36 36
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 39 44 43 61 61 90 81 125 104 130
Provision for Tax 10 12 11 16 16 26 24 35 29 36
Profit After Tax 29 32 31 45 44 64 58 90 75 94
Adjustments -0 -1 -0 -0 -0 3 4 4 3 -0
Profit After Adjustments 29 31 31 45 44 67 62 94 78 94
Adjusted Earnings Per Share 7.4 7.9 8 11.4 11.4 17 15.9 24 20 24

Privi Speciality Che Profit & Loss

#(Fig in Cr.) Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 597 1024 1341 1324 1277 1404 1608 1752 2101 2565
Other Income 10 16 6 26 20 32 21 26 21 20
Total Income 608 1040 1347 1350 1297 1436 1629 1779 2122 2584
Total Expenditure 525 894 1128 1104 1067 1209 1420 1424 1643 1918
Operating Profit 82 146 218 247 230 227 209 355 479 665
Interest 20 24 29 38 24 25 70 102 92 82
Depreciation 27 43 47 57 71 75 108 123 132 144
Exceptional Income / Expenses 0 0 9 40 23 5 0 0 0 0
Profit Before Tax 36 79 152 193 158 133 31 130 255 440
Provision for Tax 8 26 57 47 41 35 10 34 70 124
Profit After Tax 27 53 94 146 117 97 21 95 185 317
Adjustments 0 0 0 0 0 0 1 -1 2 11
Profit After Adjustments 27 53 94 146 117 97 22 95 187 328
Adjusted Earnings Per Share 7.2 14.2 24.1 37.4 29.9 24.9 5.7 24.3 47.9 83.9

Privi Speciality Che Balance Sheet

#(Fig in Cr.) Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 444 488 576 612 723 812 829 924 1103
Minority's Interest 0 0 0 0 0 7 6 17 14
Borrowings 66 77 181 226 332 381 404 445 511
Other Non-Current Liabilities 25 31 39 33 32 47 51 61 58
Total Current Liabilities 403 457 630 513 454 929 1101 896 1103
Total Liabilities 939 1053 1426 1384 1540 2176 2391 2343 2791
Fixed Assets 388 435 498 598 598 704 1017 1034 1156
Other Non-Current Assets 67 77 127 58 242 419 172 166 271
Total Current Assets 485 541 801 728 700 1053 1202 1142 1363
Total Assets 939 1053 1426 1384 1540 2176 2391 2343 2791

Privi Speciality Che Cash Flow

#(Fig in Cr.) Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 12 16 85 15 33 20 24
Cash Flow from Operating Activities 17 107 21 216 149 5 49 354 281
Cash Flow from Investing Activities -67 -81 -139 -176 -242 -320 -133 -180 -294
Cash Flow from Financing Activities -89 -20 122 28 23 333 72 -171 39
Net Cash Inflow / Outflow -140 5 4 68 -69 17 -12 4 26
Closing Cash & Cash Equivalent 7 12 16 85 15 33 20 24 50

Privi Speciality Che Ratios

# Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 7.21 14.19 24.13 37.38 29.93 24.93 5.69 24.3 47.87
CEPS(Rs) 14.34 25.7 36.12 51.92 48.1 44.04 33.22 56.02 81.02
DPS(Rs) 1 1.5 2.5 1.5 2 2 0 2 5
Book NAV/Share(Rs) 117.7 129.47 147.37 156.68 184.96 207.8 212.24 236.64 282.48
Core EBITDA Margin(%) 11.31 12.48 15.68 16.63 16.42 13.88 11.67 18.75 21.8
EBIT Margin(%) 8.72 9.86 13.31 17.36 14.23 11.25 6.26 13.21 16.51
Pre Tax Margin(%) 5.59 7.57 11.17 14.52 12.38 9.45 1.93 7.41 12.11
PAT Margin (%) 4.26 5.11 6.95 11.01 9.15 6.93 1.32 5.45 8.79
Cash Profit Margin (%) 8.48 9.26 10.4 15.29 14.7 12.25 8.07 12.49 15.06
ROA(%) 2.89 5.36 7.6 10.4 8 5.24 0.93 4.03 7.2
ROE(%) 6.13 11.48 17.74 24.59 17.52 12.69 2.59 10.88 18.22
ROCE(%) 7.25 13 19.17 21.11 15.36 10.64 5.58 12.22 16.88
Receivable days 99.76 70.7 75.49 77.01 66.81 65.48 63.62 66.98 64.42
Inventory Days 141.22 83.95 80.47 95.36 95.83 124.57 160.66 151.93 125.75
Payable days 115.18 76.27 81.89 84.18 78.85 107.03 116.54 93.78 78.7
PER(x) 75.96 26.57 19.21 11.17 28.34 75.35 184.75 40.78 35.66
Price/Book(x) 4.65 2.91 3.14 2.66 4.58 9.04 4.95 4.19 6.04
Dividend Yield(%) 0.18 0.4 0.54 0.36 0.24 0.11 0 0.2 0.29
EV/Net Sales(x) 3.94 1.68 1.7 1.54 3 5.85 3.19 2.75 3.68
EV/Core EBITDA(x) 28.57 11.8 10.43 8.28 16.64 36.09 24.56 13.58 16.14
Net Sales Growth(%) 0 71.49 30.92 -1.26 -3.59 9.96 14.54 8.98 19.91
EBIT Growth(%) 0 85.41 75.49 27.48 -20.98 -13.11 -36.35 130.04 49.9
PAT Growth(%) 0 96.69 76.65 54.95 -19.95 -16.7 -78.15 348.49 93.6
EPS Growth(%) 0 96.69 70.08 54.95 -19.95 -16.7 -77.19 327.22 97.03
Debt/Equity(x) 0.72 0.67 0.85 0.82 0.73 1.12 1.27 1.06 1
Current Ratio(x) 1.2 1.18 1.27 1.42 1.54 1.13 1.09 1.27 1.24
Quick Ratio(x) 0.59 0.67 0.69 0.78 0.79 0.47 0.37 0.54 0.52
Interest Cover(x) 2.78 4.3 6.22 6.13 7.68 6.25 1.45 2.28 3.76
Total Debt/Mcap(x) 0.16 0.23 0.27 0.31 0.16 0.12 0.26 0.25 0.17

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +20% +14% +10%
Operating Profit CAGR +35% +28% +14%
PAT CAGR +95% +24% +5%
Share Price CAGR +26% +41% +25% +27%
ROE Average +18% +11% +12% +14%
ROCE Average +17% +12% +12% +13%

Privi Speciality Che Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 60.6 %
FII 1.38 %
DII (MF + Insurance) 10.67 %
Public (retail) 39.4 %
# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 74.0574.0574.0574.0574.0574.0569.8969.8960.660.6
FII 0.960.620.480.430.480.41.471.331.641.38
DII 3.43.372.842.52.091.953.94.5510.2410.67
Public 25.9525.9525.9525.9525.9525.9530.1130.1139.439.4
Others 0000000000
Total 100100100100100100100100100100

Privi Speciality Che Peer Comparison

Chemicals Edit Columns

Privi Speciality Che Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Privi Speciality Che Pros & Cons

Pros

  • Debtor days have improved from 93.78 to 78.7days.

Cons

  • Company has a low return on equity of 11% over the last 3 years.
  • Stock is trading at 8.9 times its book value.
  • The company has delivered a poor profit growth of 4% over past five years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp